Drug price regulator NPPA today revised ceiling prices of five scheduled drug formulations used in treatment of various ailments, including seizures, epilepsy and allergic rhinitis, among others.
In a notification, the National Pharmaceutical Pricing Authority (NPPA) said it has revised the prices of phenobarbitone tablet 30mg, sodium valproate tablet 200mg, pheniramine injection 22.75 mg/ml of 2 ml pack, pheniramine injection 22.75 mg/ml of 10 ml pack and adrenaline injection of 1mg/ml.
The NPPA fixes ceiling price of essential medicines of Schedule I under the Drugs (Prices Control) Order (DPCO) 2013.
The government had notified DPCO 2013, which covers 680 formulations, with effect from May 15, 2014, replacing the 1995 order that regulated prices of only 74 bulk drugs.
Set up in 1997, NPPA has been entrusted with the task of fixing and revising prices of pharma products, enforcement of provisions of DPCO and monitoring the prices of controlled and decontrolled drugs.
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)